Skip to content
  • Sunday, 26 July 2026
  • 1:47 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Penn State Researchers Identify Brain Cell Lattice as Key Gatekeeper Against Alzheimers Disease
Neuroscience & Brain Research

Penn State Researchers Identify Brain Cell Lattice as Key Gatekeeper Against Alzheimers Disease

Rifan Muazin Jul 24, 2026 0

The intricate architecture of the human brain relies on a delicate balance of nutrient absorption and waste management, a process…

Read More
Neuroscience & Brain Research

Experimental Molecule OLE Identified as Potential Breakthrough in Restoring Microglial Function and Combating Alzheimers Disease

Rifan Muazin Jun 19, 2026 0

Researchers at the Institute for Neurosciences in Spain and the École Polytechnique Fédérale de Lausanne in Switzerland have announced the…

Read More
Neuroscience & Brain Research

Scientists Uncover the Biological Mechanism Behind Lecanemab and the Role of Microglia in Clearing Alzheimers Plaques

Rifan Muazin Apr 4, 2026 0

Lecanemab, a monoclonal antibody treatment marketed under the brand name Leqembi, represents a significant milestone in the clinical management of…

Read More
Neuroscience & Brain Research

Breakthrough Research Identifies Molecular Death Complex Driving Alzheimers Disease and Potential Therapeutic Inhibitor

Rifan Muazin Mar 31, 2026 0

A collaborative research effort led by neurobiologist Professor Dr. Hilmar Bading at Heidelberg University has uncovered a fundamental molecular mechanism…

Read More
Neuroscience & Brain Research

Molecular Breakthrough in Alzheimers Pathology Reveals Neurotoxic Death Complex as Key Therapeutic Target

Rifan Muazin Mar 23, 2026 0

A collaborative research effort led by neurobiologist Prof. Dr. Hilmar Bading at Heidelberg University’s Interdisciplinary Center for Neurosciences (IZN) has…

Read More
Neuroscience & Brain Research

Scientific Study Unveils Five Biological Pathways Linking Microplastics to Neurodegenerative Diseases Like Alzheimers and Parkinsons

Rifan Muazin Mar 21, 2026 0

The global proliferation of plastic pollution has moved beyond an environmental crisis into the realm of a significant public health…

Read More
Molecular Switch Discovery in Sperm Metabolism Paves the Way for Nonhormonal Male Contraceptives and Enhanced Infertility TreatmentsScience News: A Century of Illuminating the Frontiers of KnowledgeEarly skeleton map reveals how bones form in humansThe Atlantic Meridional Overturning Circulation may be near a tipping point, researchers say
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ